Advansource Biomaterials Corpora (ASNB) 0.0691 $ASNB
BUYINS.NET: ASB SqueezeTrigger Price is $16.71. There is $114,324,616 That Short Sellers Still Need To Cover.
M2 - Wed Jan 27, 11:24AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring ADVANSOURCE BIOMATERIALS COR (NYSE:ASB) in real time and just received an alert that ASB is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 6776800 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $16.71. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
ASB: 16.99 (-0.16)
AdvanSource Biomaterials Announces Multi-Year Supply Agreement with Prominent Healthcare OEM
BusinessWire - Tue Dec 08, 10:10AM CST
AdvanSource Biomaterials Corporation (OTCQB: ASNB), a leading developer of advanced polymer materials for a broad range of medical devices, today announced it has entered into a multi-year supply agreement with a global leader in radiography and imaging technology. The Agreement provides for year over year volume increases of a custom developed polyester urethane product line.
AdvanSource Biomaterials Engages Mirus Securities Inc. as Its Strategic Advisor
BusinessWire - Thu Dec 03, 9:00AM CST
AdvanSource Biomaterials Corporation (OTCQB:ASNB), a leading developer of advanced polymer materials for a broad range of medical devices, today announced the engagement of Mirus Securities Inc. ("Mirus"
. Mirus, an investment bank located in the metropolitan Boston area with in-depth experience within the med-tech manufacturing space, has been engaged for the purpose of providing guidance and assessing strategic alternatives.
AdvanSource Biomaterials Reports Fiscal 2016 Second Quarter Results and Third Consecutive Quarterly Profit
BusinessWire - Mon Nov 23, 2:00PM CST
AdvanSource Biomaterials Corporation (OTCQB: ASNB), a leading developer of advanced polymer materials for a broad range of medical devices, today announced financial results for its fiscal 2016 second quarter ended September 30, 2015 resulting in its third quarter of consecutive profitability.
Global Biocompatible Materials Industry
PR Newswire - Tue Dec 16, 10:11AM CST
This report analyzes the worldwide markets for Biocompatible Materials in US$ Million by the following Product Segments: Polymeric Materials, Metallic Materials, Natural Materials, and Other Materials. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 59 companies including many key and niche players such as -
BUYINS.NET: ASB SqueezeTrigger Price is $16.71. There is $114,324,616 That Short Sellers Still Need To Cover.
M2 - Wed Jan 27, 11:24AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring ADVANSOURCE BIOMATERIALS COR (NYSE:ASB) in real time and just received an alert that ASB is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 6776800 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $16.71. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
ASB: 16.99 (-0.16)
AdvanSource Biomaterials Announces Multi-Year Supply Agreement with Prominent Healthcare OEM
BusinessWire - Tue Dec 08, 10:10AM CST
AdvanSource Biomaterials Corporation (OTCQB: ASNB), a leading developer of advanced polymer materials for a broad range of medical devices, today announced it has entered into a multi-year supply agreement with a global leader in radiography and imaging technology. The Agreement provides for year over year volume increases of a custom developed polyester urethane product line.
AdvanSource Biomaterials Engages Mirus Securities Inc. as Its Strategic Advisor
BusinessWire - Thu Dec 03, 9:00AM CST
AdvanSource Biomaterials Corporation (OTCQB:ASNB), a leading developer of advanced polymer materials for a broad range of medical devices, today announced the engagement of Mirus Securities Inc. ("Mirus"
. Mirus, an investment bank located in the metropolitan Boston area with in-depth experience within the med-tech manufacturing space, has been engaged for the purpose of providing guidance and assessing strategic alternatives. AdvanSource Biomaterials Reports Fiscal 2016 Second Quarter Results and Third Consecutive Quarterly Profit
BusinessWire - Mon Nov 23, 2:00PM CST
AdvanSource Biomaterials Corporation (OTCQB: ASNB), a leading developer of advanced polymer materials for a broad range of medical devices, today announced financial results for its fiscal 2016 second quarter ended September 30, 2015 resulting in its third quarter of consecutive profitability.
Global Biocompatible Materials Industry
PR Newswire - Tue Dec 16, 10:11AM CST
This report analyzes the worldwide markets for Biocompatible Materials in US$ Million by the following Product Segments: Polymeric Materials, Metallic Materials, Natural Materials, and Other Materials. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 59 companies including many key and niche players such as -
